Early detection of hepatocellular carcinoma (HCC) is crucial for improving patient outcomes and offers the best chance for curative treatment, making HCC screening a vital strategy for high-risk ...

A case study of a patient with Niemann-Pick disease who developed hepatocellular carcinoma highlights the importance of screening in this population. A case report published in American Journal of ...

Cumulative patient survival according to alfafetoprotein (AFP) level. Results are shown for cases with AFP < 20 μg/L () and > 20 μg/L ()AFP < 20 μg/L vs AFP > 20 μg/L ( P -value 0.35). The cumulative ...

A recent study found that screening for hepatocellular carcinoma (HCC) is associated with reduced mortality, highlighting the need to promote HCC screening for patients with known risk factors. One of ...

Hepatocellular carcinoma (HCC) screening in patients with cirrhosis or chronic hepatitis B virus (HBV) infection is associated with improved early-stage detection and survival benefits that persist ...

Phase III results of exatecan (DX-8951f) versus gemcitabine (Gem) in chemotherapy-naïve patients with advanced pancreatic cancer (APC) No significant financial relationships to disclose. This is an ...

Please provide your email address to receive an email when new articles are posted on . Hepatocellular carcinoma was detected with screening in 42.3% vs. 57.7% without screening. Screen detection was ...

Prevention of HCC Related to Metabolic Syndrome was awarded to our researchers by the National Cancer Institute in 2022 with the goal of reducing the burden of liver cancer in patients with metabolic ...

Genetron Holdings Ltd. said its blood-based, early screening test for hepatocellular carcinoma (HCC) demonstrated 88% sensitivity and 93% specificity in 1,615 subjects in China vs. 71% sensitivity and ...

Genetron Holdings Ltd. said its blood-based, early screening test for hepatocellular carcinoma (HCC) demonstrated 88% sensitivity and 93% specificity in 1,615 subjects in China vs. 71% sensitivity and ...